This content is machine translated Migraine Fremanezumab for comorbid migraine and depression Migraine and depression often reinforce each other and make treatment more difficult. The UNITE study shows that the CGRP antibody fremanezumab significantly reduces both migraine days and depressive symptoms –...…
View Post 4 min This content is machine translated Migraine prophylaxis with CGRP-mAb New sub-analysis on fremanezumab shows risks of treatment breaks At this year’s congress of the European Association of Neurology (EAN) in Helsinki, a sub-analysis of the PEARL data was presented, which shows possible negative effects of treatment breaks on…
View Post 3 min This content is machine translated Migraine prophylaxis Positive long-term data on fremanezumab The CGRP inhibitor proved to be an effective and safe medication in patients with chronic and episodic migraine when used over a 12-month period. Data from the extension study were…
